Third Rock Ventures as of Sept. 30, 2014
Portfolio Holdings for Third Rock Ventures
Third Rock Ventures holds 6 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sage Therapeutics (SAGE) | 42.9 | $368M | 12M | 31.50 | |
| Agios Pharmaceuticals (AGIO) | 22.0 | $188M | 3.1M | 61.35 | |
| Zafgen | 12.8 | $110M | 5.6M | 19.65 | |
| Foundation Medicine | 10.9 | $93M | 4.9M | 18.96 | |
| Eleven Biotherapeutics | 6.3 | $54M | 4.8M | 11.14 | |
| Bluebird Bio (BLUE) | 5.1 | $44M | 1.2M | 35.88 |
